FOLLOW US

  • facebook
  • twitter
Wed

March 4, 2026

French Inventiva $150M Share Sale

America November 13, 2025

French Inventiva $150M Share Sale: Biopharma Expands Offering to Fund Clinical Trials

French biopharmaceutical company Inventiva SA on Thursday revealed it has expanded its U.S. share sale to approximately $150 million, as…

By Rihem Akkouche

Merck & Co receive $700 million from Blackstone

America November 4, 2025

Merck & Co Receive $700 Million From Blackstone to Boost Cancer Drug Development

In a move set to reshape cancer drug financing, Merck & Co. announced Tuesday that it will receive $700 million…

By Rihem Akkouche

Pfizer Sues Metsera

America November 1, 2025

Pfizer Sues Metsera to Block Novo Nordisk’s $9B “Bribe” Deal

In a dramatic escalation of a high-stakes biopharma showdown, Pfizer Inc. has filed suit in Delaware Chancery Court to stop…

By Rihem Akkouche

Novo Nordisk $2.1 billion licensing deal

America October 15, 2025

Novo Nordisk Inks $2.1B Licensing Deal for Rare Disease Breakthrough

In a bold move to deepen its footprint in rare disease treatment, Novo Nordisk SA announced Wednesday that it will…

By Rihem Akkouche

MannKind to acquire ScPharmaceuticals

America August 25, 2025

MannKind to Acquire ScPharmaceuticals in $360M Deal

MannKind Corp., advised by Cooley LLP, announced Monday it will acquire ScPharmaceuticals Inc., represented by Latham & Watkins LLP, in…

By Rihem Akkouche

Jazz Pharmaceuticals to Acquire Chimerix

America March 5, 2025

Jazz Pharmaceuticals to Acquire Chimerix for $935M

In a move set to reshape the oncology market, Jazz Pharmaceuticals announced Wednesday its plans to acquire Chimerix in a…

By Rihem Akkouche

Sandoz's Allegations of Market Poisoning in Hypertension Medication Trial

America April 30, 2024

Sandoz’s Allegations of Market Poisoning in Hypertension Medication Trial

In a striking courtroom drama unfolding in New Jersey federal court, Sandoz Inc. has accused biopharmaceutical giant United Therapeutics Corp.…

By Rais Lilia

Signup for the USA Herald
exclusive Newsletter